In preclinical trials, a sensitive functional test is required to detect changes in the motor behaviour of the SOD1G93A mouse model of amyotrophic lateral sclerosis (ALS). We evaluated changes in body weight and motor impairment in behavioural tests, such as the rotarod, the hanging-wire test and the treadmill, of transgenic and wild type mice. We found differences in detection of the onset of symptoms and progression of the disease between the different tests assessed. Moreover, the data showed significant gender differences in the motor behaviour of this mouse model. The rotarod and the hanging-wire test were more sensitive to detect early motor impairment. Moreover, the results suggested that the rotarod and hanging-wire became the most accurate tests rather than treadmill to characterise the ALS disease phenotype.
In preclinical trials, a sensitive functional test is required to detect changes in the motor behaviour of the SOD1G93Amouse model of amyotrophic lateral sclerosis (ALS). We evaluated changes in body weight and motor impairment in behavioural tests, such as the rotarod, the hanging-wire test and the treadmill, of transgenic and wild type mice. We found differences in detection of the onset of symptoms and progression of the disease between the different tests assessed. Moreover, the data showed significant gender differences in the motor behaviour of this mouse model. The rotarod and the hanging-wire test were more sensitive to detect early motor impairment. Moreover, the results suggested that the rotarod and hanging-wire became the most accurate tests rather than treadmill to characterise the ALS disease phenotype.
Amyotrophic lateral sclerosis (ALS) is a lethal neurodegenerative disorder that causes
progressive paralysis and death within 3–5 years of diagnosis. During the last 20 years, the
mouse model overexpressing SOD1 has been one of the most important research tools for
scientists working in the field of ALS [18]. One of
the best characterised SOD1transgenicmouse strains carries the humanSOD1G93A mutation. In
this model, the SOD1 gene contains a glycine to alanine substitution at position 93, which
results in a toxic gain of SOD1 function [10, 24]. The high copy mutant SOD1G93Amice are
phenotypically healthy until approximately 80–90 days old, when they develop symptoms of
motor neuron disease, such as shaking limbs when suspended [4]. After 120 days, most of these mice are in the end stages of disease and become
completely paralysed.The SOD1G93Amice develop a progressive paralysis starting in the hind limbs via
denervation of the neuromuscular junction. This denervation prompts an active degeneration
of ventral root axons and a significant loss of alpha motor neurons. The moment at which
early motor deficits appear needs to be accurately defined, especially when therapeutic
strategies are tested. A thorough understanding of the motor behaviour of the mouse model as
well as the motor function tests available is vital for the correct development of a
behavioural analysis. Therefore, several methods should be considered in order to select the
approach that most accurately addresses the experimental questions.Semi-quantitative or descriptive methods (e.g., observation or stride length analysis) were
initially used by researchers for assessing motor function in SOD1G93Amice [10]. Various tests, such as rotarod, hanging-wire, foot
print or treadmill tests [2, 5, 15] have been performed to
detect the onset and progression of neurodegenerative diseases when an experimental
treatment is being studied. The treadmill was first used as a training system to study and
test the motor phenotype [12, 20]. Currently, complex and expensive systems based on computerised
treadmill data are used to analyse walking pattern and to calculate standardised gait
parameters [11, 16, 23]. This system has been less
frequently emploied, and consequently, less information about it has been reported. Thus,
the purpose of this work was to compare the conventional behavioural tests, such as rotarod
or hanging-wire tests, to the treadmill. The experimental variables included changes in body
weight, survival rate, and motor function assessed with the rotarod, hanging-wire and
treadmill tests.
Materials and Methods
Animals
Animals were purchased from The Jackson Laboratory (B6SJL-Tg (SOD1-G93A) 1Gur/J) and were
housed under a standard light:dark (12:12 h) cycle. Animals were provided with food and
water ad libitum in the Servicio General de Apoyo a la Investigación-SAI
of the Universidad de Zaragoza. Hemizygotic transgenic mice were obtained by mating
transgenic males with F1 hybrid females (B6SJL). Transgenic mice were identified by PCR
assay of DNA extracted from the tail with specific primers for humanSOD1 (according to
The Jackson Laboratory protocol). Wild type (WT) littermates were used as controls of the
transgenic mice for behavioural tests. All of the procedures were approved by the in-house
Ethics Committee for Animal Experiments of the Universidad de Zaragoza. Animal care and
experimentation were performed according to the Spanish Policy for Animal Protection
RD53/2013, which meets the European Union Directive 2010/63 on the protection of animals
used for experimental and other scientific purposes.During late-stage disease, access to food and water were provided. Euthanasia was
performed when mice failed to right themselves within 30 s of being placed on their side
(disease endpoint) [4].Body weight and behaviour tests were performed weekly during the morning, beginning at
postnatal (P) day 60 until the death of the animals.
Rotarod test
Motor coordination, strength and balance were assessed using a rotarod (ROTA-ROD/RS,
LE8200, LSILETICA Scientific Instruments; Panlab, Barcelona, Spain). Mice started to train
on the rotarod daily one week before recording the data. Animals were placed onto the
cylinder at a constant speed of 14 rpm. The animals had three attempts to remain on the
rotarod for a maximum of 180 s per trial, and the longest latency was recorded.
Hanging-wire test
Neuromuscular strength was tested by the hanging-wire test. Each mouse was placed on a
wire lid of a conventional housing cage and the lid was turned upside down. The latency
from the beginning of the test until the mouse stood with at least two limbs on the lid
was timed. The animals had three attempts to stand for a maximum of 180 s per trial, and
the longest latency was recorded.
Treadmill
Animals were subjected to involuntary exercise on a rodent treadmill (1055SDRM Columbus
Instruments, Columbus, OH, USA). Motor activity was registered 3 days per week beginning
at 45 days of age. To encourage the mice to run, the treadmill was equipped with an
electrical shock grid at the rear of the treadmill. The shock grid was set to deliver 0.3
mA, which caused an uncomfortable shock but did not physically harm or injure the animals.
Three speeds were analysed (11, 22 and 44 cm/s) during 10 mins at 5° incline. Performance
was measured based on the time each mouse stayed on the shock grid. The more disease
progression an animal had experienced, the more time it spent on the shock grid.
Statistical analysis
Statistical analysis for all behavioral data consisted of analyses of variance (ANOVA) to
compare genotypes (SOD1G93A and WT) and gender (males and females). Significant
differences were further evaluated using Bonferroni’s method for post hoc comparisons.
Differences in body weight were examined using Student’s t-test. Survival
and disease onset were plotted on Kaplan-Meier curves and analysed using the log-rank
test. Statistical analyses were performed in SPSS version 19.0 (IBM). Data were presented
as mean ± the standard error of the mean (SEM). Significance was set at a
p-value of less than 0.05.
Results
Body weight and survival
As shown in the Fig. 1A, wild type animals, or control group, increased their weight continuously and they
never showed motor symptoms. From P61 to P142 the transgenic males always weighted more
than females (P<0.01). Maximum weight was reached at P103 in males and
females, from this time the weight started to decrease gradually. At the end of the
experiment, transgenic animals lost up to 27% (males) and 16% (females) of his maximum
weight. From P117 the weight loss was more important and fast in transgenic mice.
Furthermore, comparing wild type mice to their transgenic mate of different sex
separately, the weight loss began to be significant around P96
(P<0.05) in males while in females, this loss was found at P117
(P<0.05).
Fig. 1.
Body weight and survival time. (A) Changes over time in weight of male (black) and
female (grey) wild type and transgenic mice (WT males n=10, WT females n=10,
transgenic females n=43 and transgenic males n=43). Data are shown as mean ± SEM.
(B) Kaplan-Meier survival comparison of the male and female transgenic mice. No
significant differences were detected between transgenic male and female mice.
Body weight and survival time. (A) Changes over time in weight of male (black) and
female (grey) wild type and transgenic mice (WT males n=10, WT females n=10,
transgenic females n=43 and transgenic males n=43). Data are shown as mean ± SEM.
(B) Kaplan-Meier survival comparison of the male and female transgenic mice. No
significant differences were detected between transgenic male and female mice.When survival time was analyzed, no statistical significant difference was observed
between males and females (Fig. 1B). Transgenic
males showed a mean life span of 135.6 ± 1.6 days, while the mean in females was observed
at 137.7 ± 1.6 days.Significant differences between control and transgenic mice was observed at P89
(P<0.05) and P96 (P<0.001) until the endpoint.
In particular, some transgenic males showed early symptoms around P75, although from P82
these symptoms became more evident (Fig. 2). In contrast females showed early symptoms at P82 and started to decline around
P96, although the performance was worse from P103, which was coincident with the maximum
weight observed (P<0.05, P<0.001). During disease
progression significant differences were not detected between transgenic males and
females, and in both sexes, a similar progression was observed, showing transgenic male
mice more motor deficits than transgenic female mice.
Fig. 2.
Rotarod test. Changes over time in rotarod test performance of male (black) and
female (grey) wild type and transgenic mice (WT males n=10, WT females n=10,
transgenic females n=15 and transgenic males n=15). Data are shown as mean ± SEM.
*P<0.05 and
***P<0.001 (male mice),
†P<0.05 and
†††P<0.001 (female mice).
Rotarod test. Changes over time in rotarod test performance of male (black) and
female (grey) wild type and transgenic mice (WT males n=10, WT females n=10,
transgenic females n=15 and transgenic males n=15). Data are shown as mean ± SEM.
*P<0.05 and
***P<0.001 (male mice),
†P<0.05 and
†††P<0.001 (female mice).Motor symptoms appeared earlier in transgenic males (P68) than transgenic females (P82),
although in both sexes a similar test evolution was observed (Fig. 3A). The decline began to be significant at P82 (P<0.05) and
continued until the end (P<0.001) when control and transgenic mice,
males and females, were compared. Significant differences between transgenic male and
female mice were detected at P103, which was coincident with the maximum weight observed,
P110 and P117 days of life, in which the most important and fast loss of weight was
registered (P<0.01).
Fig. 3.
Hanging-wire test. Changes over time in hanging-wire test of male (black) and
female (grey) wild type and transgenic mice (WT males n=10, WT females n=10,
transgenic females n=15 and transgenic males n=15). Data are shown as mean ± SEM.
*P<0.05 and
***P<0.001 (male mice),
†P<0.05 and
†††P<0.001 (female mice).
Hanging-wire test. Changes over time in hanging-wire test of male (black) and
female (grey) wild type and transgenic mice (WT males n=10, WT females n=10,
transgenic females n=15 and transgenic males n=15). Data are shown as mean ± SEM.
*P<0.05 and
***P<0.001 (male mice),
†P<0.05 and
†††P<0.001 (female mice).When the speed was set at 11 cm/s on the treadmill, the first motor deficits were
detected at P109 in transgenic males and P120 in transgenic females (Fig. 4A). However, significant motor function began to get worse at P116
(P<0.05) in males and P123 in females (P<0.05),
becoming gradually aggravated (P<0.001). At 22 cm/s alterations in
motor function were detected earlier at P104 in males and at P108 in females (Fig. 4B). Significant differences were detected at
P111 in males and at P118 in females and form these points significance increased
(P<0.001). Finally, at 44 cm/s some animals had problems to reach
the performance from the beginning, showing males more motor difficulties than females
(Fig. 4C). Significant differences at P106 in
males and P111 in females, comparing to wild-type, were visible
(P<0.05) and motor dysfunction became more evident at P113
(P<0.001). At P74, transgenic mice (males and females) showed the
first alteration in their motor behaviour.
Fig. 4.
Treadmill. The shock time (s) was registered at 3 speeds (11, 22 and 44 cm/s) from
P45 to P137 (WT males n=10, WT females n=10, transgenic females n=10 and transgenic
males n=10). Data are shown as mean ± SEM. (A) Results at 11 cm/s. (B) Results at 22
cm/s. (C) Results at 44 cm/s. *P<0.05 and
***P<0.001 (male mice),
†P<0.05 and
†††P<0.001 (female mice).
Treadmill. The shock time (s) was registered at 3 speeds (11, 22 and 44 cm/s) from
P45 to P137 (WT males n=10, WT females n=10, transgenic females n=10 and transgenic
males n=10). Data are shown as mean ± SEM. (A) Results at 11 cm/s. (B) Results at 22
cm/s. (C) Results at 44 cm/s. *P<0.05 and
***P<0.001 (male mice),
†P<0.05 and
†††P<0.001 (female mice).
Discussion
The most objective and simple parameter to first characterize transgenicSOD1G93Amice is
the body weight, which is also virtually observer independent. ALS, in fact, is accompanied
by a significant weight loss in both human and mice.Studies of SOD1G93Amice confirmed that changes in body weight occurred as a sign of motor
neuron death over the course of the disease. This is a rather unspecific characteristic and
it can be due to many conditions such as dehydratation or malnutrition, developmental
abnormalities [6], background strain [23] or orolingual motor deficits [19]. However, the age at which these changes occur differs substantially
among published studies. Our results are coincident with the ones described by Azari [3], Hayworth [12]
or Smittkamp [19] who reported stable body weight in
transgenic mice from P55 to P125 to finally decrease during end-stage disease. Furthermore,
reported differences in body weight between transgenic mice and control mice emerging from
P98 to P126 have been also described [1, 20, 22]. Therefore
these results suggested that weight loss was not an accurate measurement of disease onset or
progression in this animal model of ALS.Differences between transgenic male and female mice have been described in several studies,
not only about weight or survival, but also about onset and progression disease [7, 21]. In case of
survival rate, genetic background studies in this model described longer survival in
transgenic females than in transgenic males [1, 7, 13], albeit
females survived two more days than males in our study, no significant gender differences
were detected [12, 14]. Moreover we found that transgenic male mice exhibited more severe symptoms
including earlier onset and motor deficits than transgenic female mice in each behaviour
test assessed. In rotarod, hanging-wire test and treadmill, the male mice showed deficits
before females, therefore the differences in disease progression between males and females
are obvious. But only in the case of hanging-wire test significant differences appeared
between transgenic male and female mice, so our results are consistent with previous reports
that transgenic females displayed motor symptom later than transgenic male mice with no
evidence of higher survival rates. These discrepancies may be related to the copy number of
the transgene, the mouse background, the experimental protocol (food supplies in final
stage) or estrogens effects [7]. On view of these
results, we recommend that gender should be taken into account in experimental design since
the behavioural differences seem to contribute to variability.The most frequently used analysis of motor impairment in mice is the rotarod test which let
us register how long the animals were able to run on a rotating cylinder [22]. The rotarod test is a complex task that requires
good motor coordination and balance in addition to strength; a decline in motor strength is
specific for ALS disease. Hence a decline in rotarod performance is a rather indirect
measurement of the motor deficit. However, the lack of sensitivity of this test to detect
motor deficits prior to the onset of clinical symptoms has been widely discussed and other
tests have been also used to expand the time frame to detect early changes [3, 14]. Although
the first motor dysfunction evidence appeared in the pre-symptomatic phase (P75 in males and
P82 in females), transgenic male mice showed this motor dysfunction 2 weeks later while
transgenic female mice displayed it 3 weeks later since the deficits began to be
significant. The performance progression observed for this test was similar to that
described by Alves [1] or Smittkamp [19]. The wide variety of results could be explained by
differences in training days, protocols performance or genetic background of mice model.
Overall, previous experiences in our group have demonstrated that animals must be training
before, and the training should realize at least one week before starting the experiments in
order to ensure proper test development if early symptoms want to be detected [17].The hanging-wire test requires only balance and grip strength [6] and there is no need for any significant training of the mice. The
simplicity (a conventional cage lid), reliability and improved diagnostic accuracy of this
test are a great advantage. Our results are in agreement with Hayworth [12], and Smittkampp [19] which reported the first muscle limb weakness changes at P68 in transgenic
females and P82 in transgenic males. Moreover we found that disease progression was better
endured by transgenic female mice than transgenic male mice, which is in accordance to Choi
[7], and this gender differences were significant
during symptomatic stage (P103, P110 and P117). Therefore, we could be able to detect early
motor performance deficits, suggesting this test as a good choice among the rest.Treadmill-based systems have been suggested as a better way to monitor gait dysfunction and
disease progression in models of genetic neurological disorders [11, 23] and as a training system
to evaluate the benefit of physical activity in ALS [13, 21]. As compared to the methods that do
not use computerized acquisition and analysis (footprints), the computerized gait analysis
systems are marketed as a more efficient, sensitive and reliable way to measure motor
deficits [9]. This system can incorporate a video
camera for capture of paw placement, so parameters like stride, swing or stance time are
able to be analyzed [16].Among the speeds we applied in this test, we found that the slow and medium speeds (11 and
22 cm/s) were unable to detect motor deficits before P100, and as a consequence it was
possible that mice could offset the loss of hind limb muscle strength, unlike the results
observed in the rotarod test. When we worked at 44 cm/s the deficits were detected before
(around P74), which is in agreement with Guillot [9]
and Wooley [23]. At this point, the treadmill was
able to detect early symptoms as well as the rotarod or the hanging-wire test. We therefore
suggest, an intermediate speed between 22 and 44 cm/s, that could be enough to detect early
motor symptoms and therefore it could not cause excessive attrition, especially in the case
of transgenic male mice. Moreover, this system is also able to change the conditions of the
test (belt inclination for example), so new protocols of resistance and strength are
possible; and the training is not required. In addition, these results are in accordance
with the speed range used in the same animal model [8]
and highlight the importance of using a particular speed value in treadmill, especially when
further molecular and cellular studies are needed. However, comparing treadmill to rotarod
test we found a best sensitivity in rotarod test as we could detect the first significant
motor deficit symptoms in transgenic mice at P90 in rotarod test while this detection was
found since P106 in treadmill.The results show gender differences in the motor impairment, so balanced groups must be
taken into account in the experimental design in order to avoid any sex bias. The clinical
phenotype in SOD1transgenic mice is perfectly characterized by the conventional behavioural
tests such as rotarod and hanging-wire, as shown by the data. Moreover, our results
suggested that the use of rotarod and hanging-wire can represent the most accurate
behavioural tests to monitor the disease progression in SOD1transgenic mice. However, the
sensitivity of treadmill in our experimental conditions was not comparable to the other
tests, undermining its use when a precise monitoring of the disease is needed.
Conflict of Interest
The authors declare that they have no conflict of interest.
Authors: Albert C Ludolph; Caterina Bendotti; Eran Blaugrund; Adriano Chio; Linda Greensmith; Jean-Philippe Loeffler; Richard Mead; Heiko G Niessen; Susanne Petri; Pierre-Francois Pradat; Wim Robberecht; Markus Ruegg; Birgit Schwalenstöcker; Detlev Stiller; Leonard van den Berg; Fernando Vieira; Stephan von Horsten Journal: Amyotroph Lateral Scler Date: 2010
Authors: Thomas S Guillot; Seneshaw A Asress; Jason R Richardson; Jonathan D Glass; Gary W Miller Journal: J Mot Behav Date: 2008-11 Impact factor: 1.328
Authors: Luca Madaro; Magda Passafaro; David Sala; Usue Etxaniz; Francesca Lugarini; Daisy Proietti; Maria Vittoria Alfonsi; Chiara Nicoletti; Sole Gatto; Marco De Bardi; Ricardo Rojas-García; Lorenzo Giordani; Sara Marinelli; Vittoria Pagliarini; Claudio Sette; Alessandra Sacco; Pier Lorenzo Puri Journal: Nat Cell Biol Date: 2018-07-26 Impact factor: 28.824
Authors: Eduardo J Pérez-Torres; Irina Utkina-Sosunova; Vartika Mishra; Peter Barbuti; Mariangels De Planell-Saguer; Georgia Dermentzaki; Heather Geiger; Anna O Basile; Nicolas Robine; Delphine Fagegaltier; Kristin A Politi; Paola Rinchetti; Vernice Jackson-Lewis; Matthew Harms; Hemali Phatnani; Francesco Lotti; Serge Przedborski Journal: Proc Natl Acad Sci U S A Date: 2022-06-24 Impact factor: 12.779
Authors: René Günther; Alexander Balck; Jan C Koch; Tobias Nientiedt; Michael Sereda; Mathias Bähr; Paul Lingor; Lars Tönges Journal: Front Pharmacol Date: 2017-01-31 Impact factor: 5.810
Authors: Amaya Rando; Miriam de la Torre; Anna Martinez-Muriana; Pilar Zaragoza; Antonio Musaro; Sara Hernández; Xavier Navarro; Janne M Toivonen; Rosario Osta Journal: PLoS One Date: 2019-01-14 Impact factor: 3.240